Barrigel - Radiotherapy protection spacer

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
22-07-2020

から入手可能:

Palette Life Sciences Australia Pty Ltd

クラス:

Class III

製:

Palette Life Sciences 27 E Cota Street Suite 402, Santa Barbara, CA, 93101 United States Of America

治療領域:

60424 - Radiotherapy protection spacer

適応症:

Barrigel is a sterile, transparent, biodegradable gel of stabilized hyaluronic acid of non-animal origin, supplied in a glass syringe. Barrigel acts by adding volume to the tissue, thereby mechanically creating an increased distance between the prostate and the anterior rectal wall. The product degrades over time. Barrigel is used to increase the distance between the prostate and the anterior rectal wall, with the intent to decrease radiation dose delivered to the rectum when treating prostate cancer with radiation.

認証ステータス:

A

承認日:

2020-07-21

この製品に関連するアラートを検索